Immunotherapy for Breast Cancer
Physician-evaluated NK cell immunotherapy for patients diagnosed with Breast Cancer - at any stage.
Breast Cancer: Overview
A breast cancer diagnosis often leads to immediate decisions around surgery, chemotherapy, and radiation. While these treatments are essential in many cases, some patients seek additional options that support the body beyond conventional approaches.
Natural Killer (NK) Cell Immunotherapy offers a complementary path — focused on strengthening your immune system's natural ability to recognize and respond to abnormal cells.
"Supporting the immune system is not a replacement for established treatment — it is an additional strategy that many patients want to explore."
Giostar Medical Team
Why early action is Critical
Breast cancer is one of the most common cancers worldwide — and its progression can vary significantly.
u.s. lifetime risk
1 in 8
women will be diagnosed with breast cancer during their lifetime.
global cancer impact
Leading cause of death
from cancer among women globally
Advanced disease may affect
Energy levels and vitality
Hormonal balance
Physical comfort and mobility
Emotional well-being
Some forms of breast cancer are aggresive and can progress rapidlly. Delaying action may reduce available options and impact long-term outcomes.
Why Consider Cellular Immunotherapy?
Traditional cancer treatments are designed to remove or destroy cancer cells. Immunotherapy works differently — by supporting your body's internal defense system. NK cells play a key role in identifying and eliminating abnormal cells without prior exposure.
In breast cancer, particularly in recurrent or advanced cases, immune-based approaches may help support ongoing disease control.
Nk cell mechanism
How Natural Killer Cells Target Cancer
Tumor Cell
Cancer cells evade normal immune detection
NK Recognition
NK cells detect "missing self" signals on abnormal cells
Cytotoxic Release
NK cells deploy perforin and granzymes
Cell Elimination
Tumor cell undergoes targeted aproptosis
In the clinical program, NK cells are collected from the patient, expanded in a controlled laboratory setting, and reinfused under physician oversight — supporting the body's own immune targeting capacity.
NK Cell Therapy is designed to:
Enhance immune surveillance
Support identification and elimination of abnormal cells
Complement conventional treatments
Provide a systemic, whole-body approach
Are You a Candidate?
NK Cell Immunotherapy may be considered for patients who:
Have been diagnosed with breast cancer (any stage, subject to evaluation)
Are exploring complementary or alternative treatment options
Have experienced recurrence or progression
Are seeking a less invasive, immune-based approach
Want to support their immune system during or after treatment
Every case is individually reviewed by our medical team to determine eligibility and design a personalized protocol.
Not all breast cancer patients qualify for our program. Eligibility is determined individually through physician-led medical review. This page provides general educational context — not medical advice or a determination of suitability.
A More Comprehensive Approach
At GIOSTAR, treatment goes beyond cellular therapy. Your program may include:
Enhance immune surveillance
Support identification and elimination of abnormal cells
Complement conventional treatments
Provide a systemic, whole-body approach
Clinical process
How the Process Works
Medical Evaluation
Your diagnosis, medical history, and treatment goals are reviewed by our physicians.
Immune Profiling & Blood Collection
A blood sample is collected to isolate immune cells and assess baseline function.
NK Cell Expansion
NK cells are activated and expanded in our specialized laboratory.
Controlled Reinfusion
Expanded NK cells are administered intravenously under clinical protocols.
Monitoring & Follow-Up
Progress is tracked through advanced laboratory testing and physician follow-up.
Next Step: Medical Review
If you or a family member has been diagnosed with breast cancer and is exploring additional options, the first step is to submit your case for physician review. Our team will assess your specific situation and respond with an eligibility determination.